CDK7-targeted therapy effectively disrupts cell cycle progression and oncogenic signaling in head and neck cancer
{{output}}
Head and neck squamous cell carcinoma (HNSCC) remains a prevalent and aggressive malignancy, characterized by a lack of targeted therapies and limited clinical benefits. Here, we conducted an optimized whole-genome CRISPR screen across five HNSCC cell lines ai... ...
